Abstract
Feline and human mucopolysaccharidosis VI (MPS VI or Maroteaux–Lamy syndrome) are inherited autosomal recessive deficiencies of lysosomal enzyme arylsulphatase B1–6. Affected cats and children exhibit lesions caused by incompetent degradation, retinal atrophy and excessive urinary excretion of dermatan facial dysmorphia, corneal stromal opacities, leukocyte granulation, retinal atrophy and excessive urinary excretion of dermatan sulphate—and usually die before adulthood7–11. Most attempts to treat humans affected with MPS VI or other mucopolysaccharidoses have been ineffective or logistically prohibitive12–21, but allogeneic bone marrow transplantation (BMT) offers promise for cure of certain inborn errors of metabolism22–24. Engraftment of normal donor marrow may endow the enzyme-deficient recipient with a continuous source of enzyme-competent blood cells and tissue macrophages to facilitate degradation of stored substrate and to prevent genesis of further malformations. To test this hypothesis, we performed allogeneic BMT in a 2-year-old male Siamese cat with advanced MPS VI. Here we describe BMT-induced correction of this hereditary enzyme deficiency.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jezyk, P. F., Haskins, M. E., Patterson, D. F., Mellman, W. J. & Greenstein, M. Science 198, 834–836 (1977).
Haskins, M. E. et al. Animal Models of Inherited Metabolic Diseases, 177–201 (Liss, New York, 1982).
Thrall, M. A., Hall, R. L. & Snyder, S. P. Proc. 33rd A. Meet. Am. Coll. vet. Path., 149 (1982).
Maroteaux, P. & Lamy, M. J. Pediat. 67, 312–323 (1965).
Spranger, J. W. et al. Helv. paediat. Acta 25, 337–362 (1970).
Fluharty, A. L. J. invest. Derm. 79, 38s–44s (1982).
Stumpf, D. A., Austin, J. H., Crocker, A. C. & LaFrance, M. Am. J. Dis. Child. 126, 747–773 (1973).
Rasmussen, H. & Bordier, P. The Physiological and Cellular Basis of Metabolie Bone Disease, 88–90 (Williams & Wilkins, Baltimore, 1974).
deBernard, B., Stagni, N., Colautti, I., Vittur, F. & Bonucci, E. Clin. Orthop. 126, 285–291 (1977).
Haskins, M. E., Aquirre, G. D., Jezyk, P. F. & Patterson, D. F. Am. J. Path. 101, 657–674 (1980).
Aquirre, G. D., Stramm, L. E. & Haskins, M. E. Invest. Ophthalmol. Vis. Sci. 24, 991–1007
DiFerrante, N. et al. Proc. natn. Acad. Sci. U.S.A. 68, 303–307 (1971).
Erickson, R. P., Sandman, R., Robertson, W. V. B. & Epstein, C. J. Pediatrics 50, 693–701 (1972).
Knudson, A. G., DiFerrante, N. & Curtis, J. E. Proc. natn. Acad. Sci. U.S.A. 68, 1738–1741 (1971).
Nishioka, J., Mizushima, T. & Ono, K. Clin. Orthop. 140, 194–203 (1979).
Toma, L., Pinto, W., Nader, H. B. & Dietrich, C. P. Braz. J. med. Res. 16, 29–33 (1983).
Vine, D. T. et al. J. clin. Invest. 69, 294–302 (1982).
Dean, M. F. et al. Nature 257, 609–612 (1975).
Dean, M. F. et al. Nature 261, 323–325 (1976).
Gibbs, D. A., Spellacy, E., Tompkins, R., Watts, R. W. E. & Mowbray, J. F. J. inher. metab. Dis. 6, 62–81 (1983).
Brown, F. R. et al. Am. J. med. Genet. 13, 309–318 (1982).
Hobbs, J. R. Lancet ii, 735–739 (1981).
Bayever, E. & Feig, S. A. Recent Advances in Bone Marrow Transplantation, 185–195 (Liss, New York, 1983).
Kadota, R. P. Mayo Clin. Proc. 59, 171–184 (1984).
Neufeld, E. F., Sando, G. N., Garvin, A. J. & Rome, L. H. J. supramolec. Struct. 6, 95–101 (1977).
Olsen, I., Dean, M. F., Harris, G. & Muir, H. Nature 291, 244–247 (1981).
Olsen, I., Dean, M. F., Muir, H. & Harris, G. J. Cell Sci. 55, 211–231 (1982).
Olsen, I., Muir, H., Smith, R., Fensom, A. & Watt, D. J. Nature 306, 75–77 (1983).
Scaravilli, F. & Suzuki, K. Nature 305, 713–715 (1983).
Hobbs, J. R. et al. Lancet ii, 709–712 (1981).
Hobbs, J. R. Expl Hemat. 10, Suppl. 10, 48–49 (1982).
Hugh-Jones, F. Expl Hemat. 10, Suppl. 10, 50–51 (1982).
Krivit, W. et al. Blood 60, 170a (1982).
Bayever, E., Feig, S. A., Philippart, M. & Brill, N. Clin. Res. 31, 107a (1983).
Desai, S. et al. Expl Hemat. 11, Suppl. 13, 98–100 (1983).
Peck, A. B. & Bach, F. H. J. immun. Meth. 3, 147–150 (1973).
Rojko, J. L., Hoover, E. A., Quackenbush, S. L. & Olsen, R. G. Nature 298, 385–388 (1982).
Pennock, C. A. J. clin. Path. 29, 111–123 (1976).
Baum, H., Dodgson, K. S. & Spencer, B. Clin. chim. Acta 4, 453–455 (1959).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gasper, P., Thrall, M., Wenger, D. et al. Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation. Nature 312, 467–469 (1984). https://doi.org/10.1038/312467a0
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/312467a0
This article is cited by
-
Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases
Springer Seminars in Immunopathology (2004)
-
Umbilical cord blood transplantation for Maroteaux–Lamy syndrome (mucopolysaccharidosis type VI)
Bone Marrow Transplantation (2000)
-
Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation
Gene Therapy (1999)
-
Bone mineral density in feline mucopolysaccharidosis VI measured using dual-energy X-ray absorptiometry
Calcified Tissue International (1995)
-
Lysosomal storage diseases: mechanisms of enzyme replacement therapy
The Histochemical Journal (1993)